Cathelicidin peptide rescues G. mellonella infected with B. anthracis

References

• Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287:2236-52; PMID:11980524; http://doi.org/10.1001/jama.287.17.2236
   PubMed Web of Science ®Google Scholar
• Guichard A, Nizet V, Bier E. New insights into the biological effects of anthrax toxins: linking cellular to organismal responses. Microbes Infect 2012; 14:97-118; PMID:21930233; http://doi.org/10.1016/j.micinf.2011.08.016
   PubMed Web of Science ®Google Scholar
• Hancock RE, Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 2002; 206:143-9; PMID:11814654; http://doi.org/10.1111/j.1574-6968.2002.tb11000.x
   PubMed Web of Science ®Google Scholar
• De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 2005; 27:1337-47; PMID:16215847; http://doi.org/10.1007/s10529-005-0936-5
   PubMed Web of Science ®Google Scholar
• de Latour FA, Amer LS, Papanstasiou EA, Bishop BM, van Hoek ML. Antimicrobial activity of the Naja atra cathelicidin and related small peptides. Biochem Biophys Res Commun 2010; 396:825-30; PMID:20438706; http://doi.org/10.1016/j.bbrc.2010.04.158
   PubMed Web of Science ®Google Scholar
• Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 2008; 76:4176-82; PMID:18591225; http://doi.org/10.1128/IAI.00318-08
   PubMed Web of Science ®Google Scholar
• Chung MC, Dean SN, van Hoek ML. Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37. Biochem J 2015; 470:243-53; PMID:26188040; http://doi.org/10.1042/BJ20150432
   PubMed Web of Science ®Google Scholar
• Propst CN, Pylypko SL, Blower RJ, Ahmad S, Mansoor M, van Hoek ML. Francisella philomiragia infection and lethality in mammalian tissue culture cell models, galleria mellonella, and BALB/c Mice. Front Microbiol 2016; 7:696; PMID:27252681; http://doi.org/10.3389/fmicb.2016.00696
   PubMedGoogle Scholar
• Dean SN, Bishop BM, van Hoek ML. Susceptibility of pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37. Front Microbiol 2011; 2:128; PMID:21772832; http://doi.org/10.3389/fmicb.2011.00128
   PubMed Web of Science ®Google Scholar
• Dean SN, Bishop BM, van Hoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 2011; 11:114; PMID:21605457; http://doi.org/10.1186/1471-2180-11-114
   PubMed Web of Science ®Google Scholar
• Blower RJ, Barksdale SM, van Hoek ML. Snake cathelicidin NA-CATH and smaller helical antimicrobial peptides are effective against burkholderia thailandensis. PLoS Negl Trop Dis 2015; 9:e0003862; PMID:26196513; http://doi.org/10.1371/journal.pntd.0003862
   PubMed Web of Science ®Google Scholar
• Lisanby MW, Swiecki MK, Dizon BL, Pflughoeft KJ, Koehler TM, Kearney JF. Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol 2008; 181:4989-5000; http://doi.org/10.4049/jimmunol.181.7.4989
   PubMed Web of Science ®Google Scholar
• Wang W, Mulakala C, Ward SC, Jung G, Luong H, Pham D, Waring AJ, Kaznessis Y, Lu W, Bradley KA, et al. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem 2006; 281:32755-64; PMID:16790431; http://doi.org/10.1074/jbc.M603614200
   PubMed Web of Science ®Google Scholar
• O'Driscoll NH, Labovitiadi O, Cushnie TP, Matthews KH, Mercer DK, Lamb AJ. Production and evaluation of an antimicrobial peptide-containing wafer formulation for topical application. Curr Microbiol 2013; 66:271-8; PMID:23183933; http://doi.org/10.1007/s00284-012-0268-3
   PubMedGoogle Scholar
• Welkos S, Cote CK, Hahn U, Shastak O, Jedermann J, Bozue J, Jung G, Ruchala P, Pratikhya P, Tang T, et al. Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections. Antimicrob Agents Chemother 2011; 55:4238-50; PMID:21768520; http://doi.org/10.1128/AAC.00267-11
   PubMed Web of Science ®Google Scholar
• Ahmad S, Hunter L, Qin A, Mann BJ, van Hoek ML. Azithromycin effectiveness against intracellular infections of Francisella. BMC Microbiol 2010; 10:123; PMID:20416090; http://doi.org/10.1186/1471-2180-10-123
   PubMed Web of Science ®Google Scholar
• Aperis G, Fuchs BB, Anderson CA, Warner JE, Calderwood SB, Mylonakis E. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect 2007; 9:729-34; PMID:17400503; http://doi.org/10.1016/j.micinf.2007.02.016
   PubMed Web of Science ®Google Scholar
• McKenney ES, Sargent M, Khan H, Uh E, Jackson ER, San Jose G, Couch RD, Dowd CS, van Hoek ML.. Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy. PloS One 2012; 7:e38167; PMID:23077474; http://doi.org/10.1371/journal.pone.0038167
   PubMed Web of Science ®Google Scholar
• Champion OL, Cooper IA, James SL, Ford D, Karlyshev A, Wren BW, Duffield M, Oyston PC, Titball RW.. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis. Microbiology 2009; 155:1516-22; PMID:19383703; http://doi.org/10.1099/mic.0.026823-0
   PubMed Web of Science ®Google Scholar
• Mukherjee K, Altincicek B, Hain T, Domann E, Vilcinskas A, Chakraborty T. Galleria mellonella as a model system for studying Listeria pathogenesis. Appl Environ Microbiol 2010; 76:310-7; PMID:19897755; http://doi.org/10.1128/AEM.01301-09
   PubMed Web of Science ®Google Scholar
• Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC, Jr., Mylonakis E. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53:2605-9; PMID:19332683; http://doi.org/10.1128/AAC.01533-08
   PubMed Web of Science ®Google Scholar
• Thomas RJ, Hamblin KA, Armstrong SJ, Muller CM, Bokori-Brown M, Goldman S, Atkins HS, Titball RW. Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei. Int J Antimicrob Agents 2013; 41:330-6; PMID:23402703; http://doi.org/10.1016/j.ijantimicag.2012.12.009
   PubMed Web of Science ®Google Scholar
• Ramarao N, Nielsen-Leroux C, Lereclus D. The insect galleria mellonella as a powerful infection model to investigate bacterial pathogenesis. J Vis Exp 2012:e4392; PMID:23271509; http://dx.doi.org/10.3791/4392
   PubMedGoogle Scholar
• Jacobs AC, Thompson MG, Black CC, Kessler JL, Clark LP, McQueary CN, Gancz HY, Corey BW, Moon JK, Si Y, et al. AB5075, a highly virulent isolate of acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. MBio 2014; 5:e01076-14; PMID:24865555; http://doi.org/10.1128/mBio.01076-14
   PubMed Web of Science ®Google Scholar
• Harding CR, Schroeder GN, Collins JW, Frankel G. Use of Galleria mellonella as a model organism to study Legionella pneumophila infection. J Vis Exp 2013: (81)e50964; PMID:24299965; http://dx.doi.org/10.3791/50964
   PubMedGoogle Scholar
• Plaut RD, Kelly VK, Lee GM, Stibitz S, Merkel TJ. Dissemination bottleneck in a murine model of inhalational anthrax. Infect Immun 2012; 80:3189-93; PMID:22753373; http://doi.org/10.1128/IAI.00515-12
   PubMed Web of Science ®Google Scholar
• Popova TG, Teunis A, Espina V, Liotta LA, Popov SG. Chemokine-releasing microparticles improve bacterial clearance and survival of anthrax spore-challenged mice. PLoS One 2016; 11:e0163163; PMID:27632537; http://doi.org/10.1371/journal.pone.0163163
   PubMed Web of Science ®Google Scholar
• Brogden KA, Nordholm G, Ackermann M. Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific. Vet Microbiol 2007; 119:76-81; PMID:16997510; http://doi.org/10.1016/j.vetmic.2006.08.005
   PubMedGoogle Scholar
• Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF.. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 2000; 68:2748-55; PMID:10768969; http://doi.org/10.1128/IAI.68.5.2748-2755.2000
   PubMed Web of Science ®Google Scholar
• Larrick JW, Hirata M, Shimomoura Y, Yoshida M, Zheng H, Zhong J, Wright SC. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother 1993; 37:2534-9; PMID:8109914; http://doi.org/10.1128/AAC.37.12.2534
   PubMedGoogle Scholar
• Luna VA, King DS, Gulledge J, Cannons AC, Amuso PT, Cattani J. Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods. J Antimicrob Chemother 2007; 60:555-67; PMID:17586563; http://doi.org/10.1093/jac/dkm213
   PubMed Web of Science ®Google Scholar
• Takagi S, Hayashi S, Takahashi K, Isogai H, Bai L, Yoneyama H, Ando T, Ito K, Isogai E. Antimicrobial activity of a bovine myeloid antimicrobial peptide (BMAP-28) against methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Anim Sci J 2012; 83:482-6; PMID:22694332; http://doi.org/10.1111/j.1740-0929.2011.00979.x
   PubMedGoogle Scholar
• Pompilio A, Scocchi M, Pomponio S, Guida F, Di Primio A, Fiscarelli E, Gennaro R, Di Bonaventura G.. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides 2011; 32:1807-14; PMID:21849157; http://doi.org/10.1016/j.peptides.2011.08.002
   PubMed Web of Science ®Google Scholar
• Giacometti A, Cirioni O, Ghiselli R, Bergnach C, Orlando F, D'Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Skerlavaj B, et al. The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis. Crit Care Med 2004; 32:2485-90; PMID:15599155; http://doi.org/10.1097/01.CCM.0000148221.09704.22
   PubMed Web of Science ®Google Scholar
• Kaplan ELM, P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53:457-81; ; http://doi.org/10.1080/01621459.1958.10501452
   Google Scholar
• Russell BH, Vasan R, Keene DR, Koehler TM, Xu Y. Potential dissemination of Bacillus anthracis utilizing human lung epithelial cells. Cell Microbiol 2008; 10:945-57; PMID:18067609; http://doi.org/10.1111/j.1462-5822.2007.01098.x
   PubMed Web of Science ®Google Scholar
• Franks SE, Ebrahimi C, Hollands A, Okumura CY, Aroian RV, Nizet V, McGillivray SM. Novel role for the yceGH tellurite resistance genes in the pathogenesis of Bacillus anthracis. Infect Immun 2014; 82:1132-40; PMID:24366250; http://doi.org/10.1128/IAI.01614-13
   PubMedGoogle Scholar
• Fedhila S, Buisson C, Dussurget O, Serror P, Glomski IJ, Liehl P, Lereclus D, Nielsen-LeRoux C. Comparative analysis of the virulence of invertebrate and mammalian pathogenic bacteria in the oral insect infection model Galleria mellonella. J Invertebr Pathol 2010; 103:24-9; PMID:19800349; http://doi.org/10.1016/j.jip.2009.09.005
   PubMed Web of Science ®Google Scholar
• Chung MC, Jorgensen SC, Tonry JH, Kashanchi F, Bailey C, Popov S. Secreted Bacillus anthracis proteases target the host fibrinolytic system. FEMS Immunol Med Microbiol 2011; 62:173-81; PMID:21395696; http://doi.org/10.1111/j.1574-695X.2011.00798.x
   PubMedGoogle Scholar
• Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 2004; 28:101-12; PMID:14975532; http://doi.org/10.1016/j.femsre.2003.09.002
   PubMed Web of Science ®Google Scholar
• Marmaras VJ, Lampropoulou M. Regulators and signalling in insect haemocyte immunity. Cell Signal 2009; 21:186-95; PMID:18790716; http://doi.org/10.1016/j.cellsig.2008.08.014
   PubMed Web of Science ®Google Scholar